Richard White, MD
Family Medicine · Lorain, OHNPI 1164637609
Payments from drug & device makers
Across 199 payments — averaging $14.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$519
- Amgen$238
- Novo Nordisk$217
- Siemens Medical Solutions USA, Inc.$195
- Novartis$181
- Pfizer$164
- plus $1K from 15 others
What the payments were for
- Food & beverage$2,797100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 32 | $519 |
| Amgen(2 entities) | 17 | $238 |
| Novo Nordisk | 27 | $217 |
| Siemens Medical Solutions USA, Inc. | 2 | $195 |
| Novartis | 18 | $181 |
| Pfizer | 21 | $164 |
| Lilly USA, LLC | 18 | $163 |
| Amarin Pharma, Inc. | 11 | $157 |
| Johnson & Johnson | 3 | $152 |
| Merck | 16 | $144 |
| Inspire Medical Systems, Inc. | 1 | $140 |
| AstraZeneca | 7 | $135 |
| Teva Pharmaceuticals USA, Inc. | 6 | $82 |
| Astellas Pharma US Inc | 4 | $82 |
| Kowa Pharmaceuticals America, Inc. | 5 | $63 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $48 |
| GSK | 3 | $37 |
| Scilex Pharmaceuticals Inc. | 2 | $36 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Boehringer Ingelheim | 1 | $14 |
| Amneal Pharmaceuticals LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SOMATOM GO$178
- MAGNETOM Terra 7T MRI Scanner$178
- Mammomat Revelation$178
- Inspire$140
- VIBERZI$125
- SPRAVATO$125
How this compares
$2,797 in reported general payments places this provider in the 75th percentile of 3,983 family medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 74 | $131,890 |
| JanuviaSitagliptin Phosphate | 76 | $91,106 |
| JardianceEmpagliflozin | 58 | $66,280 |
| EliquisApixaban | 62 | $63,563 |
| RybelsusSemaglutide | 26 | $60,465 |
| XareltoRivaroxaban | 38 | $37,168 |
| JanumetSitagliptin Phos/Metformin Hcl | 23 | $35,671 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 23 | $31,041 |
| TrulicityDulaglutide | 16 | $22,309 |
| LinzessLinaclotide | 15 | $13,614 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 18 | $13,052 |
| Breo ElliptaFluticasone/Vilanterol | 11 | $8,915 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 16 | $7,667 |
| OxycontinOxycodone Hcl | 12 | $6,873 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 13 | $6,598 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $217 | $192,355100 claims |
| MerckJanuvia, Janumet | $144 | $126,77799 claims |
| Boehringer IngelheimJardiance, Combivent Respimat | $14 | $72,87871 claims |
| PfizerEliquis | $164 | $63,56362 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta | $37 | $53,00952 claims |
| Johnson & JohnsonXarelto | $152 | $37,16838 claims |
| Lilly USA, LLCTrulicity | $163 | $22,30916 claims |
| AbbVieLinzess, Synthroid | $519 | $15,80654 claims |
| Astellas Pharma US IncMyrbetriq | $82 | $5,18312 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $14 | $4,550406 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,983 family medicine providers in Ohio.
Other family medicine in Lorain
- Michael ButcherCincinnati$18.3M
- William RandallKettering$7.5M
- Paul NugentCincinnati$4.9M
- Steve ChoiDayton$4.8M
- Martin SchearDayton$2.2M
- Rajesh DavitCincinnati$2M
- Kwabena OtengSpringdale$2M
- Blaise GattoMoraine$1.8M
- Cathy GreiweColumbus$1.4M
- Brian BeesleyColumbus$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.